Press releases
  • Home
  • > Press releases
  • > Cancer
  • > (French)Un test automatisé pour évaluer la migration cellulaire et l’efficacité de nouvelles molécules anticancéreuses

(French)Un test automatisé pour évaluer la migration cellulaire et l’efficacité de nouvelles molécules anticancéreuses

Press release | 16 Oct 2012 - 11h08 | By INSERM PRESS OFFICE
Cancer

TO CITE THIS POST :
Press release – Inserm press room (French)Un test automatisé pour évaluer la migration cellulaire et l’efficacité de nouvelles molécules anticancéreuses Link : https://presse.inserm.fr/en/french-un-test-automatis-pour-valuer-la-migration-cellulaire-et-l-efficacit-de-nouvelles-mol-cules-anticanc-reuses/4636/

Other contents In the same category :

Cancer Voir tout

communi

The composition of gut microbiota can predict the efficacy and tolerance of immunotherapy in people with cancer

Teams from AP-HP, INRA, Gustave Roussy and Inserm can demonstrate the role of microbiota in the response of immunotherapy for cancer. They show that in man, the composition of gut microbiota can help to identify the patients who will respond favourably or ...
communi

An antioxidant protein to fight changes to the intestinal microbiota and control inflammation

Teams from Hôpital Paul-Brousse AP-HP, Inserm and Paris-Sud University have recently evidenced a mechanism which modulates the intestinal microbiota, involving a molecule with antioxidant and anti-inflammatory properties, known as REG3A. The latter is thought to protect the intestinal barrier and the bacteria ...
fermer
fermer
RSS Youtube